These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17584627)

  • 1. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy.
    Saraste M; Väisänen S; Alanen A; Airas L;
    Gend Med; 2007 Mar; 4(1):45-55. PubMed ID: 17584627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells.
    Airas L; Saraste M; Rinta S; Elovaara I; Huang YH; Wiendl H;
    Clin Exp Immunol; 2008 Feb; 151(2):235-43. PubMed ID: 18062798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis.
    Langer-Gould A; Gupta R; Huang S; Hagan A; Atkuri K; Leimpeter AD; Albers KB; Greenwood E; Van Den Eeden SK; Steinman L; Nelson LM
    Arch Neurol; 2010 Jan; 67(1):51-7. PubMed ID: 20065129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta.
    Saraste M; Irjala H; Airas L
    Neurol Sci; 2007 Jun; 28(3):121-6. PubMed ID: 17603762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector T Helper Cells Are Selectively Controlled During Pregnancy and Related to a Postpartum Relapse in Multiple Sclerosis.
    Koetzier SC; Neuteboom RF; Wierenga-Wolf AF; Melief MJ; de Mol CL; van Rijswijk A; Dik WA; Broux B; van der Wal R; van den Berg SAA; Smolders J; van Luijn MM
    Front Immunol; 2021; 12():642038. PubMed ID: 33790911
    [No Abstract]   [Full Text] [Related]  

  • 6. CD3
    Tahrali I; Kucuksezer UC; Akdeniz N; Altintas A; Uygunoglu U; Aktas-Cetin E; Deniz G
    Immunol Lett; 2019 Dec; 216():63-69. PubMed ID: 31589897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.
    Bsteh G; Algrang L; Hegen H; Auer M; Wurth S; Di Pauli F; Deisenhammer F; Berger T
    Mult Scler; 2020 Jan; 26(1):69-78. PubMed ID: 30507345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.
    García-León JA; López-Gómez C; Orpez-Zafra T; Reyes-Garrido V; Marín-Bañasco C; Oliver-Martos B; Fernández O; Leyva L
    CNS Drugs; 2014 Jun; 28(6):559-70. PubMed ID: 24599774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period.
    Winkelmann A; Rommer PS; Hecker M; Zettl UK
    CNS Neurosci Ther; 2019 Jan; 25(1):78-85. PubMed ID: 29858532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
    Vukusic S; Durand-Dubief F; Benoit A; Marignier R; Frangoulis B; Confavreux C
    Mult Scler; 2015 Jun; 21(7):953-5. PubMed ID: 25305253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy in Multiple Sclerosis: A Portuguese cohort study.
    Jesus-Ribeiro J; Correia I; Martins AI; Fonseca M; Marques I; Batista S; Nunes C; Macário C; Almeida MC; Sousa L
    Mult Scler Relat Disord; 2017 Oct; 17():63-68. PubMed ID: 29055477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study.
    Fares J; Nassar AH; Gebeily S; Kobeissy F; Fares Y
    BMJ Open; 2016 May; 6(5):e011210. PubMed ID: 27178979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in natural killer cell activity in normal pregnant and postpartum women: increases in the first trimester and postpartum period and decrease in late pregnancy.
    Hidaka Y; Amino N; Iwatani Y; Kaneda T; Mitsuda N; Morimoto Y; Tanizawa O; Miyai K
    J Reprod Immunol; 1991 May; 20(1):73-83. PubMed ID: 1875329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland.
    Jalkanen A; Alanen A; Airas L;
    Mult Scler; 2010 Aug; 16(8):950-5. PubMed ID: 20542921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
    Nikfar S; Rahimi R; Abdollahi M
    Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis.
    Haas J; Hommes OR
    Mult Scler; 2007 Aug; 13(7):900-8. PubMed ID: 17881400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy.
    Watanabe M; Iwatani Y; Kaneda T; Hidaka Y; Mitsuda N; Morimoto Y; Amino N
    Am J Reprod Immunol; 1997 May; 37(5):368-77. PubMed ID: 9196795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4.
    Furlan R; Bergami A; Lang R; Brambilla E; Franciotta D; Martinelli V; Comi G; Panina P; Martino G
    J Neuroimmunol; 2000 Nov; 111(1-2):86-92. PubMed ID: 11063825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
    Hughes SE; Spelman T; Gray OM; Boz C; Trojano M; Lugaresi A; Izquierdo G; Duquette P; Girard M; Grand'Maison F; Grammond P; Oreja-Guevara C; Hupperts R; Bergamaschi R; Giuliani G; Lechner-Scott J; Barnett M; Edite Rio M; van Pesch V; Amato MP; Iuliano G; Slee M; Verheul F; Cristiano E; Fernández-Bolaños R; Poehlau D; Saladino ML; Deri N; Cabrera-Gomez J; Vella N; Herbert J; Skromne E; Savino A; Shaw C; Moore F; Vucic S; Petkovska-Boskova T; McDonnell G; Hawkins S; Kee F; Butzkueven H;
    Mult Scler; 2014 May; 20(6):739-46. PubMed ID: 24107309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and disability in interferon-β-1b treated and untreated women with multiple sclerosis.
    Trenova AG; Slavov GS; Manova MG; Kostadinova II
    Arch Med Res; 2014 Aug; 45(6):495-500. PubMed ID: 25130430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.